PlainRecalls
FDA Devices Moderate Class II Ongoing

IMPIX C+, REF numbers: a) B20240104, b) B20240105, c) B20240106, d) B20240107, e) B20240205, f) B20240206, g) B20240207, h) B20240208; intervertebral fusion device - cervical

Reported: August 30, 2023 Initiated: July 12, 2023 #Z-2460-2023

Product Description

IMPIX C+, REF numbers: a) B20240104, b) B20240105, c) B20240106, d) B20240107, e) B20240205, f) B20240206, g) B20240207, h) B20240208; intervertebral fusion device - cervical

Reason for Recall

There is a potential for a product packaging non-conformity issue which presents as a pinhole in either the inner or outer pouch.

Details

Recalling Firm
Medicrea International
Units Affected
0 (US)
Distribution
US nationwide
Location
Rillieux La Pape, N/A

Frequently Asked Questions

What product was recalled?
IMPIX C+, REF numbers: a) B20240104, b) B20240105, c) B20240106, d) B20240107, e) B20240205, f) B20240206, g) B20240207, h) B20240208; intervertebral fusion device - cervical. Recalled by Medicrea International. Units affected: 0 (US).
Why was this product recalled?
There is a potential for a product packaging non-conformity issue which presents as a pinhole in either the inner or outer pouch.
Which agency issued this recall?
This recall was issued by the FDA Devices on August 30, 2023. Severity: Moderate. Recall number: Z-2460-2023.